- 专利标题: Drug combination of PDE3/PDE4 inhibitor and muscarinic receptor antagonist
-
申请号: US15614440申请日: 2017-06-05
-
公开(公告)号: US10471063B2公开(公告)日: 2019-11-12
- 发明人: Michael J. A. Walker , Mario Cazzola , Luigino Calzetta
- 申请人: VERONA PHARMA PLC
- 申请人地址: GB Cardiff
- 专利权人: Verona Pharma PLC
- 当前专利权人: Verona Pharma PLC
- 当前专利权人地址: GB Cardiff
- 代理机构: Kilpatrick Townsend & Stockton LLP
- 主分类号: A61K31/519
- IPC分类号: A61K31/519 ; A61K31/40 ; A61K45/06 ; A61K9/00 ; A61K31/137 ; A61K31/167 ; A61K31/44 ; A61K31/46 ; A61K9/48 ; A61M15/00
摘要:
The invention provides a composition which comprises (a) a PDE3/PDE4 inhibitor which is 9,10-Dimethoxy-2-(2,4,6-trimethylphenylimino)-3-(N-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one or a pharmaceutically acceptable acid addition salt thereof and (b) a muscarinic receptor antagonist.
公开/授权文献
- US20170266190A1 DRUG COMBINATION 公开/授权日:2017-09-21